Saving Seafood

Everything You Need To Know About The Coronavirus And Seafood Safety

March 16, 2020 — The coronavirus (COVID-19) outbreak is affecting industries worldwide, and seafood is no exception. With high anxiety and fear surrounding the virus, misinformation can spread quickly as everyone tries to make sense of a rapid change of lifestyle. Here’s what you need to know about how the coronavirus affects seafood safety, according to public health professionals.

There is no evidence suggesting that the coronavirus can be spread through food products or food packaging

As of now, there’s no evidence of COVID-19 transmission through food. According to the FDA regarding the safety of consumer products: “Again, we want to reassure the public that at this time there is no evidence that food or food packaging have been associated with transmission and no reason to be concerned”.

The source of the virus is still unknown

According to the World Health Organization, there have been no confirmed animal sources of COVID-19. According to the most recent situation report from March 14th, the virus does have a live animal source, but that source is unknown at this time. However the WHO does offer the following advice as a precaution: “when visiting live animal markets, avoid direct contact with animals and surfaces in contact with animals” They advise to use good food safety practices at all times and to “handle raw meat, milk or animal organs with care to avoid contamination of uncooked foods and avoid consuming raw or undercooked animal products”. These precautions do not differ from normal food safety precautions.

Additionally, the WHO states that receiving packages from an area where COVID-19 has been reported is safe: “The likelihood of an infected person contaminating commercial goods is low and the risk of catching the virus that causes COVID-19 from a package that has been moved, travelled, and exposed to different conditions and temperature is also low”.

Read the full story at Forbes

Fishermen’s group declares “partial victory” after court ruling on GM salmon

January 3, 2020 — Even though a federal judge ruled in December that the U.S. Food and Drug Administration has the authority to regulate genetically modified salmon, a commercial fishing group that sued the agency is declaring “partial victory.”

That’s because, in May, the judge will hear arguments on the second part of the case, which questions whether the FDA’s approval of GM salmon was deficient.

Read the full story at Seafood Source

‘Frankenfish’ Salmon Can Be Overseen by FDA Despite Concerns

December 23, 2019 — The Food and Drug Administration can regulate salmon that’s genetically engineered to grow faster, according to a decision in a California federal court case over concerns about so-called frankenfish.

Fishing, consumer, and environmental groups that challenged the FDA’s approval of such salmon from AquaBounty Technologies Inc. failed to convince the court that the agency lacks authority to regulate the fish. The U.S. District Court for the Northern District of California Dec. 19 sided with the FDA, leaving to a later date a decision on whether the regulator failed to consider potential risks.

AquaBounty won the FDA’s first greenlight for changing the genetic makeup of an animal destined for the dinner table. The case could have implications for similar modifications in the works for fish like tilapia and trout or other animals down the line, according to the Center for Food Safety, one of the groups that sued.

“That’s why we were so concerned about this approval,” said Amy van Saun, a senior attorney at the center. “We want to make sure people and the environment are protected.”

Genetically engineered salmon are meant as an alternative to endangered wild salmon. AquaBounty plans to harvest its salmon starting in late 2020.

Read the full story at Bloomberg Law

Everybody knows to avoid tuna when pregnant, right? Not so fast. Eating tuna might actually yield better results, says a large new study.

November 26, 2019 — Eating ocean fish is good for you, but some fish have significant levels of methylmercury which is bad for you, so you should avoid those fish, right? Wrong, says a new study.

Mothers who ate seafood, even when it contained high levels of methyl mercury, had smarter kids than those who didnʻt eat seafood, says the comprehensive, peer-reviewed study.

“Moderate and consistent evidence indicates that consumption of a wide range of amounts and types of commercially available seafood during pregnancy is associated with improved neurocognitive development of offspring as compared to eating no seafood,” it said.

This flies in the face of conventional wisdom, and some medical wisdom. Both the U.S. Environmental Protection Agency and the U.S. Food and Drug Administration recommend against pregnant women eating ahi, over concerns about methyl mercury exposure.

There is no question that thereʻs methylmercury in yellowfin, bigeye and bluefin tuna, and that the amount has been increasing in recent years. There are also significant amounts of mercury in blue marlin and other species.

The Hawai`i Department of Health warns against pregnant women eating any blue marlin, swordfish and shark and recommends severe limits on consumption of tunas.

Read the full story at Raising Islands

For Your Heart, Eat Fish Or Take Pills? Now There’s A Drug Equal To 8 Salmon Servings

November 25, 2019 — It’s long been known that eating fish — especially cold-water fish such as salmon that are rich in omega-3 fatty acids — is good for heart health.

But, for the millions of Americans who are at high risk of heart disease, eating enough fish to make a difference isn’t likely to be realistic for most.

There’s growing evidence that taking a very high dose of purified fish oil, delivered in a prescription pill, can help prevent heart attacks and strokes among people who have elevated risks. The amount of fish oil in the daily recommended dose of the pill is the equivalent of eating about eight to 10 servings of salmon a day.

In early November, an advisory panel to the FDA voted unanimously to approve expanded use of the prescription drug, Vascepa, which is made from one type of omega-3 fatty acid, called eicosapentaenoic acid, or EPA for short. The oil is extracted from sardines and anchovies, and then purified.

Currently, Vascepa is already approved for use in people with very high levels of triglycerides — which is a type of fat in the blood. (You can check your triglycerides as part of a cholesterol screening.)

Read the full story at NPR

FDA Investigation of Scombrotoxin Fish Poisoning Linked to Yellowfin/Ahi Tuna/gassed tuna

November 20, 2019 — The following was released by the U.S. Food and Drug Administration:

FDA and state health authorities are investigating incidents of scombrotoxin fish poisoning linked to yellowfin tuna, also sometimes called ahi tuna. As a result of this investigation, FDA has placed Truong Phu Xanh Co, LTD of Vietnam on Import Alert, which provides information to FDA field staff that they may detain the firm’s yellowfin tuna without physical examination. Detained product will not enter the United States unless the importer proves that it meets U.S. food safety standards.

FDA asked for the supplier of yellowfin tuna associated with most of the illnesses, Truong Phu Xanh Co., LTD of Vietnam, to initiate a voluntary recall of all of its imported yellowfin tuna with production dates from January 2019 to the present. At this time, the firm has not recalled any product.

As part of the investigation, FDA evaluated the firm’s Hazard Analysis and Critical Control Point (HACCP) Plans. A HACCP Plan details a firm’s management system to address food safety through the analysis and control of biological, chemical, and physical hazards. Since FDA’s evaluation of this plan identified deficiencies, we asked for Truong Phu Xanh Co., LTD of Vietnam to initiate a voluntary recall of all of its imported yellowfin tuna with production dates from January 2019 to the present.
 
The investigation has identified 47 illnesses of scombrotoxin fish poisoning that occurred between August 8, 2019 and October 15, 2019.
 
Throughout the investigation, FDA and states have also been collecting product samples for testing. Scombrotoxin fish poisoning occurs when fish begin to spoil, resulting in increased histamine levels. Therefore, product samples cannot be linked to case patient samples through Whole Genome Sequencing (WGS) or Pulsed-Field Gel Electrophoresis (PFGE) analysis like for other foodborne illnesses, e.g., Salmonella or Listeria. Instead, samples are tested for decomposition and/or histamine levels. Multiple samples have been collected and analyzed, with positive results for decomposition or high histamine levels in products imported from Truong Phu Xanh Co., LTD.
 
FDA and state partners collected epidemiologic and traceback information for reported illnesses. As additional epidemiologic and traceback information was collected, FDA and state partners were able to work with companies throughout the supply chain to voluntarily recall implicated product. While recalls were conducted at various points in the supply chain, there may be additional product still on the market that could cause illness.
 
Ultimately, the coordinated investigation was able to identify Truong Phu Xanh Co., LTD as the common supplier of tuna that was likely consumed by most of the ill people.
 
Because scombrotoxin fish poisoning causes temporary or medically reversible adverse health consequences this incident did not meet the threshold for the use of FDA’s mandatory recall authority.
 
It has been determined that the source of the tuna for the illnesses announced by Seattle-King County Public Health Department is not related to Truong Phu Xanh Co., LTD.
 
Recommendations
 
Yellowfin tuna from Truong Phu Xanh Co., LTD with a production date in 2019 should not be consumed because it may have the potential to cause scombrotoxin fish poisoning. Tuna from this supplier could have been sold thawed or frozen; and could have been sold as ground tuna meat, poke cubes, steaks, or loins; this product could still be within its shelf life.­­
 
Scombrotoxin fish poisoning occurs when fish is not properly chilled or preserved and begins to spoil, resulting in increased histamine levels. Histamine cannot be destroyed by freezing or cooking.
 
Importers, Suppliers, and Distributors:
 
Importers, suppliers, and distributors should not use and should discard or destroy any yellowfin tuna imported from Truong Phu Xanh Co., LTD with a production date in 2019.
 
Restaurants and Retailers:
 
Restaurants and retailers should contact their suppliers to confirm the source of their yellowfin tuna because not all product was distributed in packaging that identifies Truong Phu Xanh Co., LTD. Yellowfin tuna imported from this company with a production date in 2019 should not be used, served, repacked, or sold; and should be discarded.
 
Consumers:
 
While we expect restaurants and retailers will have removed yellowfin tuna with a production date in 2019 from the Vietnamese supplier Truong Phu Xanh Co., LTD, consumers should ask if the yellowfin tuna being served or sold was imported from the Vietnamese supplier Truong Phu Xanh Co., LTD and has a production date in 2019.

FDA panel endorses wider use of fish-oil drug to protect against heart problems

November 15, 2019 — A panel of experts unanimously recommended Thursday that the Food and Drug Administration allow wider use of a fish oil-based drug to treat people at high risk for heart attacks and strokes even when they are taking cholesterol-lowering drugs.

The 16-0 endorsement of the FDA advisory committee puts Dublin-based Amarin Corp. one step closer to widespread distribution of Vascepa, a drug the company has said could be worth billions of dollars annually. The FDA, which usually follows such guidance, could make a long-awaited final decision next month.

“There’s a definite need for additional therapeutic approaches,” said Kenneth D. Burman, chief of the endocrine section at MedStar Washington Hospital Center, who chaired the panel. Despite some side effects, he said, “this seems a very useful new agent for addition to the armamentarium for the treatment of these patients.”

The drug, a purified version of the Omega-3 fatty acid found in fish, is aimed at some of the more than 40 million people in the U.S. who take statins to control their LDL, or “bad” cholesterol, and have adopted lifestyle changes, yet remain at risk of cardiovascular problems because of elevated triglyceride levels.

Triglycerides are another type of fat in the blood. When their levels are too high, generally more than 200 milligrams per deciliter of blood, the result can be deaths, heart attacks, strokes, unstable angina or the need for cardiac surgery.

A landmark 2018 study, led by a researcher at Brigham and Women’s Hospital and sponsored by Amarin, showed that patients who took four grams of Vascepa daily fared 25 percent better in staving off those events than those given a placebo. The researchers spent more than six years following more than 8,000 middle-aged and older patients in 11 countries who had coronary artery disease or diabetes and at least one other risk factor, such as high blood pressure.

Read the full story at The Washington Post

FDA warns about eating Kroger yellowfin tuna after illnesses

September 9, 2019 — The U.S. Food and Drug Administration is warning consumers not to eat raw yellowfin tuna steaks from several Kroger stores after some consumers became ill with scombroid poisoning.

On 4 September, the FDA became aware of multiple scombroid poisoning cases in individuals who consumed tuna steaks purchased from three separate Kroger retail locations in Ohio, the agency said in a press release.

Read the full story at Seafood Source

US lieutenant governors call for more inspections on imported seafood

July 24, 2019 — Lieutenant governors in the United States have put their weight behind a resolution sponsored by Lt. Governor Billy Nungesser (R-Louisiana) calling for additional inspections of imported seafood.

The resolution was approved at the National Lieutenant Governors Association annual meeting, which took place last week in Wilmington, Delaware. It calls on the U.S. Food and Drug Administration and the U.S. Department of Agriculture to “take immediate measures” to inspect foreign seafood, both at the point of harvest and when it enters the country.

Nungesser’s resolution was supported by Lt. Governor Susan Bysiewicz (D–Connecticut), Lt. Governor Bethany Hall-Long (D–Delaware), Lt. Governor Kate Marshall (D–Nevada) and Lt. Governor Kevin Meyer (R–Alaska).

The resolution calls on the creation of an inspection fee in the range of USD 0.05 (EUR 0.04) to USD 0.10 (EUR 0.09) per pound. Seafood caught by American fishermen and sent overseas for processing would be exempt from the inspection process.

Read the full story at Seafood Source

Groups praise updated US government seafood guidance

July 9, 2019 — U.S. seafood groups are lauding an updated government guidance that encourages pregnant and breastfeeding women and children to eat more seafood.

The U.S. Food and Drug Administration is updating its 2015-2020 Dietary Guidelines for Americans, released in 2017, which recommends that Americans eat at least eight ounces of seafood per week, based on a 2,000-calorie diet. While FDA did not increase the amount of seafood adults should eat, it is emphasizing the nutritional benefits – particularly to pregnant and breastfeeding women as well as children – of eating at least eight ounces of seafood weekly.

The agency also aims to help consumers who should limit their exposure to mercury choose from the many types of fish that are lower in mercury – “including ones commonly found in grocery stores, such as salmon, shrimp, pollock, canned light tuna, tilapia, catfish and cod,” the FDA said in a press release.

However, “it is important to note that women who might become pregnant, or who are pregnant or breastfeeding – along with young children – should avoid the few types of commercial fish with the highest levels of mercury listed on the chart,” FDA said.

Read the full story at Seafood Source